Tuesday, September 27, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

SAN DIEGO - Shareholders says Carlsbad-based Genoptix is selling itself too cheaply to Novartis, for $25 a share or $470 million.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.